Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
T cells
Adoptive cell therapy
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Remdesivir
Adoptive cell therapy
Approved by FDA Experimental Antiviral Jan/18/2023
BNT162b2
Adoptive cell therapy
Approved by FDA Experimental Vaccine Jun/22/2022
mRNA-1273
Adoptive cell therapy
Emergency use authorization Experimental Vaccine Jun/22/2022
Convalescent plasma
Adoptive cell therapy
Emergency use authorization Experimental Antiviral May/16/2022
NK cells
Adoptive cell therapy
Potential treatment - theoretical effect Used to treat other disease Antiviral Dec/23/2021
Regdanvimab
Adoptive cell therapy
Authorized Experimental Antiviral